Matches in Wikidata for { <http://www.wikidata.org/entity/Q94588964> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q94588964 description "artículu científicu espublizáu en mayu de 2020" @default.
- Q94588964 description "im Mai 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q94588964 description "scientific article published on 03 May 2020" @default.
- Q94588964 description "wetenschappelijk artikel" @default.
- Q94588964 description "наукова стаття, опублікована 3 травня 2020" @default.
- Q94588964 name "Reply to Wong C et al. "Comparison of daily dosing vs. Monday through Friday dosing of vismodegib for locally advanced basal cell carcinoma (laBCC) and basal cell nevus syndrome: a retrospective case series"" @default.
- Q94588964 name "Reply to Wong C et al. "Comparison of daily dosing vs. Monday through Friday dosing of vismodegib for locally advanced basal cell carcinoma (laBCC) and basal cell nevus syndrome: a retrospective case series"" @default.
- Q94588964 type Item @default.
- Q94588964 label "Reply to Wong C et al. "Comparison of daily dosing vs. Monday through Friday dosing of vismodegib for locally advanced basal cell carcinoma (laBCC) and basal cell nevus syndrome: a retrospective case series"" @default.
- Q94588964 label "Reply to Wong C et al. "Comparison of daily dosing vs. Monday through Friday dosing of vismodegib for locally advanced basal cell carcinoma (laBCC) and basal cell nevus syndrome: a retrospective case series"" @default.
- Q94588964 prefLabel "Reply to Wong C et al. "Comparison of daily dosing vs. Monday through Friday dosing of vismodegib for locally advanced basal cell carcinoma (laBCC) and basal cell nevus syndrome: a retrospective case series"" @default.
- Q94588964 prefLabel "Reply to Wong C et al. "Comparison of daily dosing vs. Monday through Friday dosing of vismodegib for locally advanced basal cell carcinoma (laBCC) and basal cell nevus syndrome: a retrospective case series"" @default.
- Q94588964 P1433 Q94588964-8D4CC7E0-8997-4ABC-86FA-8C134D584717 @default.
- Q94588964 P1476 Q94588964-E3719BCC-3552-47F4-80B7-8B60D0826A68 @default.
- Q94588964 P2093 Q94588964-15F5FD6A-F426-4570-9AF9-D127B6016A56 @default.
- Q94588964 P2093 Q94588964-9D0BF8DA-7CD5-49A8-A214-BFB6DEA3E2A2 @default.
- Q94588964 P2093 Q94588964-D7D8EB2D-205C-4269-A0D2-49A46411610D @default.
- Q94588964 P2093 Q94588964-E55BEC18-5DE4-4C37-9ABB-325CA2997781 @default.
- Q94588964 P31 Q94588964-45F73E9C-20C4-4A34-97E7-6A18E82469DC @default.
- Q94588964 P356 Q94588964-E8CABFE9-57C1-4163-8936-4D9894E94B34 @default.
- Q94588964 P50 Q94588964-4A9463D3-F837-46BF-BE03-470942618633 @default.
- Q94588964 P577 Q94588964-034C7488-A086-4DD3-BF93-8B17C7FC5266 @default.
- Q94588964 P698 Q94588964-3E8F6AC6-6D3F-4556-8256-425D3F668B04 @default.
- Q94588964 P356 J.JAAD.2020.03.124 @default.
- Q94588964 P698 32376431 @default.
- Q94588964 P1433 Q15757046 @default.
- Q94588964 P1476 "Reply to Wong C et al. "Comparison of daily dosing vs. Monday through Friday dosing of vismodegib for locally advanced basal cell carcinoma (laBCC) and basal cell nevus syndrome: a retrospective case series"" @default.
- Q94588964 P2093 "Alessia Villani" @default.
- Q94588964 P2093 "Claudia Costa" @default.
- Q94588964 P2093 "Massimiliano Scalvenzi" @default.
- Q94588964 P2093 "Milena Cappello" @default.
- Q94588964 P31 Q13442814 @default.
- Q94588964 P356 "10.1016/J.JAAD.2020.03.124" @default.
- Q94588964 P50 Q87750568 @default.
- Q94588964 P577 "2020-05-03T00:00:00Z" @default.
- Q94588964 P698 "32376431" @default.